Skip to main content
. 2014 Apr 13;34(2):409–430. doi: 10.1016/j.cll.2014.02.011

Table 2.

Number (%) of patients with indicated clinical and laboratory findings and human bocavirus type 1 (HBoV1) infection diagnosed serologically, as monoinfection, DNAemia, or mRNA in respiratory samples

N CXR Fever Cough Wheeze Tachypnea Dyspnea AOM Hosp. Mean Age (y) Serology DNAemia mRNA >104 cop/mL Monoinfection Ref.
15 15 (100) 14 (93.3) 13 (86.7) 8 (53.3) 11 (73.3) 1.8 15 103
12 5 (41.7) 12 (100) 12 (100) 9 (75) 9 (75) 12 (100) 12 108
10 5 (50) 9 (90) 4 (40) 4 (40) 2 (20) 7 (70) 0.8 10 9 6 104
28 8 (28.6) 18 (64.3) 28 (100) 28 (100) 1.6 28 107
12 10 (83.3) 11 (91.7) 5 (41.7) 7 (58.3) 2.3 12 7 102
14 5 (35.7) 9 (64.3) 14 (100) 14 (100) 0.8 14 109
12 9 (75) 11 (91.7) 5 (41.7) 1.3 12 10 12 48, 62
Occ.a 56.1% 67.0% 91.8% 84.6% 58.3% 59.1% 31.8% 86.8%

Serology: detection of antibodies to HBoV1 consistent with primary infection.

DNAemia, detection of HBoV1 DNA in blood.

>104 cop/mL, greater than 104 copies/mL of HBoV1 DNA in respiratory samples.

Abbreviations: AOM, acute otitis media; CXR, abnormal chest radiograph; Hosp., hospitalized patients; N, number evaluated in each study.

a

Percent occurrence of finding among all studies.